(Q44785268)
Statements
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer (English)
M Mansutti
A Martoni
G Lelli
F Buzzi
G Robustelli Della Cuna
A Jirillo
E Terzoli
L Frevola
E Tarenzi
C Sguotti
N Azli